Skip to main content
. 2010 Jul;160(5):1119–1127. doi: 10.1111/j.1476-5381.2010.00752.x

Table 2.

Selectivity of AE9C90CB, tolterodine, oxybutynin, solifenacin and darifenacin at human recombinant muscarinic receptor subtypes

Compound Fold selectivity
M1/M3 M2/M3 M4/M3 M5/M3
AE9C90CB 2 20 3 3
Tolterodine 1 1 1 0.4
Oxybutynin 2 5 1 8
Solifenacin 1 4 8 3
Darifenacin 13 25 20 5

Fold selectivity is antilog of the difference between pKi at muscarinic M3 receptors and those at M1, M2, M4, M5 subtypes.